prednisone has been researched along with Hyperlipoproteinemia Type III in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conventional therapy for type III hyperlipoproteinemia was attempted but ineffective." | 1.33 | Type III hyperlipoproteinemia with xanthomas and multiple myeloma. ( Alberta, L; Bostom, A; Burnside, NJ; Robinson-Bostom, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnside, NJ | 1 |
| Alberta, L | 1 |
| Robinson-Bostom, L | 1 |
| Bostom, A | 1 |
1 other study available for prednisone and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
Topics: Aged; Antineoplastic Agents, Alkylating; Apolipoprotein E2; Apolipoprotein E3; Apolipoproteins E; Co | 2005 |